Dehydrojuncusol


Catalog No. Size PriceQuantity
M15777-C Contact sales@xcessbio.com for quotation $100Unavailable

Description

Dehydrojuncusol, a potent HCV inhibitor, targets HCV NS5A and is able to inhibit RNA replication of replicons harboring resistance mutations to anti-NS5A direct-acting antivirals. Dehydrojuncusol significantly inhibits HCV infection when added after virus inoculation of HCV genotype 2a (EC50=1.35 µM).

Product information

CAS Number: 117824-04-1

Molecular Weight: 264.32

Formula: C18H16O2

Chemical Name: 5-ethenyl-1, 6-dimethylphenanthrene-2, 7-diol

Smiles: CC1=C2C=CC3=CC(O)=C(C)C(C=C)=C3C2=CC=C1O

InChiKey: IZVFYHBVHNNKGE-UHFFFAOYSA-N

InChi: InChI=1S/C18H16O2/c1-4-13-10(2)17(20)9-12-5-6-14-11(3)16(19)8-7-15(14)18(12)13/h4-9,19-20H,1H2,2-3H3

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

How to use

In Vitro:

Dehydrojuncusol (Huh-7 cells were infected with HCV in cell culture; 0-9.4 μM; 48 hours) inhibits HCV infection in a dose-dependent manner. Dehydrojuncusol inhibits HCV infection in Primary human hepatocytes (PHH). The EC50 of dehydrojuncusol is 1.35 µM when added continuously, 8.21 µM when added during inoculation, and 1.53 µM when added postinoculation, confirming the major effect of the molecule at the postinoculation step. The toxicity of the compound on Huh-7 cells is also tested in parallel at different time points (24 h, 48 h, and 72 h). The results shows that the CC50 of Dehydrojuncusol Is approximately 75.6 µM, which is much higher than the active dose, yielding a selective index of 56. Dehydrojuncusol is able to inhibit RNA replication of two frequent daclatasvir-resistant mutants (L31M or Y93H in NS5A). Dehydrojuncusol inhibits HCV RNA replication.

Products are for research use only. Not for human use.

Payment & Security

PayPal Venmo

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

You may also like

Recently viewed